NASDAQ: NAUTNautilus Biotechnology Inc Stock Ownership - Who owns Nautilus Biotechnology?
Insider buying vs selling
Have Nautilus Biotechnology Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Ah Equity Partners Bio II LLC | 10% Owner | 2026-06-02 | 4,615,974 | $2.35 | $10.85MSell |
| Ah Equity Partners Bio II LLC | 10% Owner | 2026-06-02 | 384,026 | $2.35 | $902.46kSell |
| Sujal M. Patel | CEO President and Secretary | 2026-03-04 | 25,000 | $2.61 | $65.25kBuy |
| Kentaro Suzuki | Chief Marketing Officer | 2025-11-06 | 4,000 | $1.49 | $5.96kBuy |
NAUT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NAUT insiders and whales buy or sell their stock.
NAUT Shareholders
What type of owners hold Nautilus Biotechnology Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Parag Mallick | 16.10% | 20,493,392 | $20.90M | Insider |
| Sujal M. Patel | 15.15% | 19,275,267 | $19.66M | Insider |
| Vijay Satyanand Pande | 13.87% | 17,653,917 | $18.01M | Insider |
| Ah Equity Partners Bio II LLC | 9.94% | 12,653,917 | $12.91M | Insider |
| Perceptive Advisors LLC | 7.16% | 9,111,151 | $9.29M | Insider |
| Matthew S. McIlwain | 5.09% | 6,479,845 | $6.61M | Insider |
| Farzad Nazem | 1.48% | 1,888,146 | $1.93M | Insider |
| Matthew L. Posard | 0.12% | 150,000 | $153.00k | Insider |
| Subramanian Sankar | 0.07% | 91,250 | $93.08k | Insider |
| Anna Mowry | 0.07% | 83,000 | $84.66k | Insider |
NAUT vs Biotech Stocks
Nautilus Biotechnology Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.